What we’re proposing
PHARMAC is seeking feedback on a proposal to list medical devices supplied by 3M New Zealand Limited (“3M”) in Part III of Section H of the Pharmaceutical Schedule from 1 December 2019.
We propose to list medical devices in the following categories:
- non-dedicated and consumable infusion devices; and
- surgical drapes, gowns and procedure packs.
Consultation closes at 1pm, Tuesday 29 October 2019 and feedback can be emailed to firstname.lastname@example.org.
What would the effect be?
From 1 December 2019 3M’s ranges of medical devices in the categories listed above would be listed under a proposed national agreement for all DHB hospitals to purchase under, subject to consultation and approval by PHARMAC’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply. DHBs would be able to continue to purchase other suppliers’ brands of non-dedicated and consumable infusion devices and surgical drapes, gowns, procedure packs.
The Agreement would supersede any existing DHB contracts with 3M for the medical devices included in the Agreement. Any medical devices listed in the Agreement, and purchased by a DHB, would be at the terms and conditions, including price, stated in the Agreement, effective from the date of listing on the Pharmaceutical Schedule.
As part of the Agreement 3M would provide appropriate training and education services that would be tailored to the individual needs of DHBs, in formats and at times as required by DHBs.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by PHARMAC.
Who we think will be interested
- Suppliers and Wholesalers
- DHB clinical staff in a range of different clinical settings inluding:
- Ambulatory care
- General wards
- Intensive care
- Infection control
- Occupational health and safety
- DHB procurement and supply chain personnel
- Other clinical care providers such as ambulance and hospice providers
About the medical devices
Infusion Devices are medical devices used, or associated with devices used, in the infusion of fluids such as medications, intravenous solutions (such as saline, glucose, and electrolyte solutions), blood, total parenteral nutrition (TPN) solutions into the body. This includes medical devices used in intravenous therapy as well as other infusion therapies.
PHARMAC’s Infusion Devices category includes:
Surgical drapes, gowns and procedure packs
Single use sterile surgical drapes are used during surgery to reduce the risk of infection of the surgical site by isolating and protecting the surgical site from exposure to microorganisms that may be present in the patient’s own microbial flora, the operating theatre environment, or on members of the surgical team.
Single use sterile surgical gowns are personal protective garments intended to be worn over the scrub suit of the operating team during surgical procedures.
Single use surgical procedure packs are delivered to operating theatres as a set of disposable medical products required for a specific surgical intervention provided in a single packed sterile pack/tray format.
Why we’re proposing this
In 2018 PHARMAC issued Requests for Proposals for
The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
PHARMAC has been working with suppliers who responded to the RFPs to seek provisional agreements and this proposal is the latest to arise from those processes.
We expect to consult on further agreements with other suppliers in these categories over the coming months.
Details about our proposal
The proposal would result in 55 medical devices of the following brands, and number of items in each category, being listed:
Surgical drapes, gowns and procedure packs
Non-dedicated and consumable infusion devices
A full product list with pricing has been made available to appropriate DHB personnel.
To provide feedback
Send us an email: email@example.com by 1pm, Tuesday 29 October 2019.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA. Anyone providing feedback, whether on their own account or on behalf of an organisation, and whether in a personal or professional capacity, should be aware that the content of their feedback and their identity may need to be disclosed in response to an OIA request.
We are not able to treat any part of your feedback as confidential unless you specifically request that we do, and then only to the extent permissible under the OIA and other relevant laws and requirements. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like it withheld. PHARMAC will give due consideration to any such request.
Last updated: 7 October 2019